Back
Neurogene 10K Form
Sell
18
NGNE
Neurogene
Last Price:
22.27
Seasonality Move:
32.14%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NGNE News And Ratings
See the #1 stock for the next 7 days that we like better than NGNE
NGNE Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-15.73M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $10.56 |
| Price / Book: | 2.66 |
Profitability
| EPS (TTM): | -3.09420 |
|---|---|
| Net Income (TTM): | $-53.25M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Neurogene Earnings Forecast
Key Neurogene Financial Ratios
- The Interest Expense is -0.03% of Operating Income.
- Per Share Earnings over the last 3 years have been positive in 0 years.
Neurogene Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | NGNE |
| Website: | neurogene.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |